$13.36
0.856.79%
At close: -
$28.35
14.99112.24%
After Hours: Mar 21, 7:56 AM EDT
Comments
Loading...
Kalbe Farma Analyst Ratings and Price Targets | OTC:PTKFY | Benzinga
Kalbe Farma Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Kalbe Farma Corp from these most-recent analyst ratings.
Analyst Ratings for Kalbe Farma
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Kalbe Farma (PTKFY) stock?
There is no price target for Kalbe Farma
What is the most recent analyst rating for Kalbe Farma (PTKFY)?
There is no analyst for Kalbe Farma
When was the last upgrade for Kalbe Farma (PTKFY)?
There is no last upgrade for Kalbe Farma
When was the last downgrade for Kalbe Farma (PTKFY)?
There is no last downgrade for Kalbe Farma.
When is the next analyst rating going to be posted or updated for Kalbe Farma (PTKFY)?
There is no next analyst rating for Kalbe Farma.
Is the Analyst Rating Kalbe Farma (PTKFY) correct?
There is no next analyst rating for Kalbe Farma.
Browse analyst ratings and price targets on all stocks.